GlassScriptPhysician profile
Usman Sheriff
NPI 1356396303
$44,688.63
in general payments reported to CMS, 2019-2025
24 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,966 · 2020: $1,035 · 2021: $382 · 2022: $1,739 · 2023: $2,828 · 2024: $5,495 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $35K · Travel and Lodging: $2,033 · Food and Beverage: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $34,666.67 |
| Travel and Lodging | $2,033.00 |
| Food and Beverage | $1,866.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $34,722.71 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Surmodics, INC. | $2,180.18 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight |
| Bard Peripheral Vascular, INC. | $1,965.81 | 2019-2023 | Venclose Maven Catheter, Crosser Iq |
| Penumbra, INC. | $1,534.45 | 2022 | |
| Philips North America LLC | $672.77 | 2019 | |
| Abiomed | $650.25 | 2020-2025 | |
| Endologix LLC | $512.31 | 2024 | Torus Stent Graft System, Endocross Device |
| Medtronic Vascular, INC. | $474.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $441.74 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $419.76 | 2019-2025 | |
| Amgen INC. | $327.21 | 2019-2025 | Repatha, Repatha |
| Medtronic USA, INC. | $241.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $164.94 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $124.16 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $86.26 | 2022-2024 | Xarelto |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $36.40 | 2025 | |
| Abbott Laboratories | $25.34 | 2024 | Perclose Proglide |
| Merck Sharp & Dohme LLC | $23.12 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.30 | 2023 | Jardiance |
| Esperion Therapeutics, INC. | $16.42 | 2023 | Nexletol |
| Amarin Pharma, INC. | $16.14 | 2020 | |
| Biotronik INC. | $15.66 | 2023 | Orsiro Mission |
| Boston Scientific Corporation | $15.15 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $4.97 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Sheriff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.